Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury

Asian Journal of Andrology

Volumn 10, Issue 1, 2008, Pages 54-59

  Bella, Anthony J ^a,b,d   Lin, Guiting ^c   Cagiannos, Ilias ^b   Lue, Tom F ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Brain derived nerve growth factor; Erectile dysfunction; Immunophilin ligands; Nerve regeneration; Neuroprotection; Neurotrophins; Postoperative complications; Prostate cancer; Radical prostatectomy; Stem cells

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; ARTEMIN; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN; CYCLOSPORIN A; ERYTHROPOIETIN; FK 1706; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GPI 1485; GROWTH DIFFERENTIATION FACTOR 5; HERPESVIRUS VECTOR; NEUROIMMUNOPHILIN; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTROPHIN; NEUROTROPHIN 4; NEURTURIN; PARVOVIRUS VECTOR; PERSEPHIN; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; CLINICAL TRIAL; CORPUS CAVERNOSUM; CRUSH TRAUMA; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; EMBRYONIC STEM CELL; ERECTILE DYSFUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; NERVE FIBER DEGENERATION; NERVE FIBER GROWTH; NERVE REGENERATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; VIRAL GENE THERAPY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ERECTILE DYSFUNCTION; ERYTHROPOIETIN; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOPHILINS; MALE; NERVE GROWTH FACTORS; NEUROTRANSMITTER AGENTS; PENIS; PERIPHERAL NERVES; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION;

EID: 37749038332     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2008.00368.x     Document Type: Review

References (43)

1. Burnett AL, Lue TF. Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery. J Urol 2006; 176: 882-7.
2. Mulhall J P, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007; 4: 538-43.
3. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where are we going? J Sex Med 2007; 4: 1085-97.
4. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532-40.
5. Mooreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113-20.
6. Bianco FJ Jr, Scardino PT, Eastham JA. Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 2005; 66 (5 Suppl): 83-94.
7. Miles C, Candy B, Jones L, Williams R, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007; 4: CD005540.
8. Bella AJ, Lin G, Tantiwongse K, Garcia M, Lin CS, Brant W, et al. Brain-derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: Part 1. J Sex Med 2006; 3: 815-20.
9. Valentine H, Chen Y, Guo Y, McCormick J, Wu Y, Sezen SF, et al. Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: New experimental paradigms. Eur Urol 2007; 51: 1724-31.
10. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int 2004; 94: 904-9.
11. Palma CA, Keast JR. Structural effects and potential changes in growth factor signaling in penis-projecting autonomic neurons after axotomy. BMC Neurosci 2006; 7: 41.
12. Bella AJ, DeYoung L, al-Numi M, Brock GB. Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications. Eur Urol 2007; 52: 990-1005.
13. Mulhall J. Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: New experimental paradigms. Eur Urol 2007; 51: 1488-9.
14. Lin G, Bella AJ, Lue T, Lin CS. Brain-derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: Part 2. J Sex Med 2006; 3: 821-9.
15. Hsieh PS, Bochinski DJ, Lin GT, Nunes L, Lin CS, Lue TF. The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int 2003; 92: 470-5.
16. Bella AJ, Lin G, Garcia MM, Tantiwonge T, Lin CS, Brant WO, et al. Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signaling pathway in the major pelvic ganglion of the rat following cavernous nerve transection. Eur Urol 2007; 52: 574-81.
17. Hiltunen JO, Laurikainen A, Klinge E, Saarma M. Neurotrophin-3 is a target derived neurotrophic factor for penile erection-inducing neurons. Neuroscience 2005; 133: 51-8.
18. Chen KC, Minor TX, Rahman NU, Ho HC, Nunes L, Lue TF. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model or neurogenic impotence. BJU Int 2005; 95: 1077-80.
19. Mitsui T, Fischer I, Shumsky JS, Murray M. Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats. Exp Neurol 2005; 194: 410-31.
20. Bella AJ, Fandel TM, Tantiwongse K, Brant WO, Klein R, Garcia CA, et al. Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Brachial Plex Peripher Nerve Inj 2007; 2: 5.
21. Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, et al. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther 2007; 14: 1344-52.
22. Laurikainen A, Hiltunen JO, Thomas-Crusells J, Vanhatalo S, Arumae U, Airaksinen MS, et al. Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol 2000; 43: 198-205.
23. Fandel T, Bella AJ, Tantiwongse K, Garcia M, Nunes L, Thuroff JW, et al. The effect of intracavernous growth differentiation factor-5 in a rat model of cavernous nerve injury. BJU Int 2006; 98: 632-36.
24. Sullivan AM, O'Keeffe GW. The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurons: relevance to Parkinson's disease treatment. J Anat 2005; 207: 219-26.
25. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Banie L, Thurhoff JW, et al. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Urol 2007; 177: 225 (Abstract 670).
26. Magit DP, Maak T, Trioano N, Raphael B, Hamouria Q, Polzhofer G, et al. Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model. Spine 2006; 31: 2180-8.
27. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK 506 is neuroprotective for penile innervation. Nat Med 2001; 710: 1073-4.
28. Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med 2007; 4: 908-16.
29. Fleischmann R, Iqbal I, Stern RL. Tacrolimus in rheumatoid arthritis. Expert Opinion Pharmacother 2006; 7: 91-9.
30. Tanaka K, Asanuma M, Ogawa N. Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem Res 2004; 29: 1529-36.
31. Hayashi N, Minor TX, Carrion R, Price RD, Nunes L, Lue TF. Erectile recovery effect of FK1706 following a bilateral cavernous nerve crush injury in a rat model. J Urol 2006; 176: 824-9.
32. Khan Z, Ferrari F, Kasper M, Tonge DA, Steiner JP, Hamilton GS, et al. The non-immunosuppressive immunophilin ligand GPI-1046 potently stimulated regenerating axon growth from adult mouse dorsal root ganglia cultured in Matrigel. Neuro-science 2002; 114: 601-9.
33. Price RD, Yamaji T, Yamamoto H, Higashi Y, Hanaoka K, Yamazaki S, Ishiye M, et al. FK1706, a novel non-immunosup-pressive immunophilin: neurotrophic activity and mechanism of action. Eur J Pharmacol 2005; 509: 11-9.
34. Bella AJ, Hayashi N, Carrion R, Price R, Lue TF. FK1706 enhances functional recovery following bilateral cavernous nerve crush injury in a rat model. J Sex Med 2007; 4: 341-47.
35. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 2004; 171: 495-500.
36. Burnett AL, McCullough AR, Smith JA Jr, Montie JE, Walsh PC, Steiner JP. Neuromodulation to preserve erectile function after radical prostatectomy: Results from the GPI 1485 neuroimmunophilin ligand clinical trial. J Urol 2007; 177: 383-4 (Abstract 1162).
37. Burnett AL, Kramer MF, Dalrymple S, Isaacs JT. Nonimmuno-suppressant immunophilin ligand GPI-1046 does not promote in vitro growth of prostate cancer cells. Urology 2005; 65: 1003-7.
38. Liu T, Allaf ME, Lagoda G, Burnett AL. Erythropoetin receptor expression in the human urogenital tract: Immunolocalization in the prostate, neurovascular bundle, and penis. BJU Int 2007; 100: 1103-6.
39. Allaf ME, Hoke A, Burnett AL. Erythropoetin promotes the recovery of erectile function following cavernous nerve injury. J Urol 2005; 174: 2060-4.
40. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int 2005; 94: 904-9.
41. Kendirci M, Spees JL, Trost L, Whitney MJ, Prockop DJ, Hellstrom WJ. Adult bone marrow stem cells isolated by the p75 nerve growth factor receptor into the corpora cavernosa promoted recovery of erectile function in cavernous nerve injury. J Sex Med 2006; 3 (Suppl 5): 384 (Abstract OR-008).
42. Bivalacqua TJ, Deng W, Kendirci M, Usta MF, Robinson C, Taylor BK, et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol 2007; 292: H1278-90.
43. Bella AJ, Garcia MM, Lin G, Fandel TM, Brant WO, Lue TF. Adult adipose tissue derived stem cells enhance neurite outgrowth from the major pelvic ganglion of the rat. CUAJ 2007; 1: 200 (Abstract 2.01).